Show simple item record

dc.creatorCurley, Duncanen
dc.date.accessioned2011-07-12T18:24:54Zen
dc.date.available2011-07-12T18:24:54Zen
dc.date.created2002en
dc.date.issued2002en
dc.identifier.bibliographicCitationJournal of Biolaw and Business 2002; 5(3): 64-68en
dc.identifier.urihttp://hdl.handle.net/10822/519947en
dc.description.abstractHaving first been proposed over a decade ago to harmonize European patent law for the benefit of Europe's fledgling biotechnology industry, the Biotechnology Patent Directive underwent a somewhat tortured introduction to adolescence when its adoption was challenged by a legal annulment from the Governments of The Netherlands, Italy and Norway. This article explores the nature of the legal challenge to the Directive, which to an extent typify European concerns about biotechnological inventions, particularly the "patenting of life."en
dc.formatArticleen
dc.languageengen
dc.source240532en
dc.subjectAdoptionen
dc.subjectBiotechnologyen
dc.subjectIndustryen
dc.subjectLawen
dc.subjectLifeen
dc.subjectNatureen
dc.subject.classificationGenetic Patentsen
dc.subject.classificationInternational and Political Dimensions of Biology and Medicineen
dc.titleTowards harmonization: the European biotechnology patent directiveen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885